Agios Pharmaceuticals, Inc.
USD37.36
-2.70 (-6.74%)
CEO
Brian Goff
IPO Date
2013-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$36.68
Prev. Close
$40.06
Day Low
$36.59
Day High
$39.26
52W Low
$22.24
52W High
$46.00
Market Cap
$2.22B
Volume
3.40M
| 1,447 |
| $0.00 |
| 2 Jul 2026 | Gheuens Sarah | Chief Medical Officer | M-Exempt | Acquired | 8,375 | $0.00 |
| 2 Jul 2026 | Gheuens Sarah | Chief Medical Officer | S-Sale | Disposed | 4,007 | $37.56 |
| 2 Jul 2026 | Gheuens Sarah | Chief Medical Officer | M-Exempt | Disposed | 8,375 | $0.00 |
| 23 Jun 2026 | Ballal Rahul D. | director | M-Exempt | Acquired | 2,816 | $0.00 |
| 23 Jun 2026 | Ballal Rahul D. | director | M-Exempt | Disposed | 2,816 | $0.00 |
| 23 Jun 2026 | Ballal Rahul D. | director | A-Award | Acquired | 2,927 | $0.00 |
| 23 Jun 2026 | Ballal Rahul D. | director | A-Award | Acquired | 14,950 | $34.16 |
| 23 Jun 2026 | CAPELLO JEFFREY D | director | M-Exempt | Acquired | 2,816 | $0.00 |
| $1,001 - $15,000 |
| 13 Jan 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 7 May 2025 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 12 Feb 2025 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 15 Feb 2024 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |